...
首页> 外文期刊>Pediatric transplantation. >The authors' reply to the comments by Urban et al. on 'Skin transplantation to monitor clinical donor-related tolerance in mixed hematopoietic chimerism' (Pediatr Transplant 2006; 10: 128-131)
【24h】

The authors' reply to the comments by Urban et al. on 'Skin transplantation to monitor clinical donor-related tolerance in mixed hematopoietic chimerism' (Pediatr Transplant 2006; 10: 128-131)

机译:作者对Urban等人评论的回复。关于“通过皮肤移植监测混合造血嵌合体临床供体相关耐受性”(Pediatr Transplant 2006; 10:128-131)

获取原文
获取原文并翻译 | 示例
           

摘要

Our case report focused on a child with chronic renal failure, in whom the potential risks of a living-related kidney donation from her mother -her former hematopoietic cell donor - had to be assessed. The method of hematopoietic cell transplantation (HCT) applied in this patient had already been described by Schwinger et al. (1). As mentioned in the discussion section, the administration of a non-myeloablative conditioning regimen before HCT may favor the continued presence of recipient hematopoiesis. If this occurs, the development of mixed chimerism bears an increased risk of hematopoietic graft rejection and treatment with donor lymphocyte infusions (DLI) to establish complete donor hematopoiesis has been recommended (2).
机译:我们的病例报告集中于一名患有慢性肾功能衰竭的儿童,在该儿童中,必须评估其母亲(她的前造血细胞供体)捐赠与生命相关的肾脏的潜在风险。 Schwinger等人已经描述了在该患者中应用的造血细胞移植(HCT)方法。 (1)。如讨论部分所述,在HCT之前实施非清髓性调理方案可能有助于继续存在受体造血功能。如果发生这种情况,混合嵌合体的发展会增加造血移植排斥反应的风险,建议使用供体淋巴细胞输注(DLI)治疗以建立完整的供体造血功能(2)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号